Handelsavisen
prelaunch
Companies Healthcare 303360.KQ
30
303360.KQ KOSDAQ Medical Equipment, Supplies & Distribution

Protia Inc

$4 210,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-7,6 %
ROE
0,4 %
Net margin
4,4 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Protia Inc is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.

Business. Protia Inc (303360.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 303360.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 303360.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Protia Inc (303360.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Protia Inc maintains a strong liquidity position, with a current ratio of 14.13, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents amount to 1,076,613,040 KRW, which supports its short-term obligations and operational flexibility. The debt-to-equity ratio is 0.01, suggesting a conservative capital structure with minimal reliance on debt financing.

    In terms of profitability, Protia Inc reported a net income of 95,206,950 KRW despite an operating loss of -164,382,710 KRW. The return on equity (ROE) is 0.004, and the return on assets (ROA) is 0.0038, both of which are relatively low, indicating that the company is not generating substantial returns relative to its equity and asset base. These metrics suggest that the company may need to improve its operational efficiency or explore new revenue streams to enhance profitability.

    The company's revenue is concentrated in the healthcare services and equipment sector, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as regulatory changes or shifts in healthcare demand. However, the lack of geographic data limits a more detailed assessment of regional exposure.

    Looking at the growth trajectory, Protia Inc's recent financial performance shows a decline in operating income, which could indicate challenges in cost management or revenue generation. The company's free cash flow is positive at 177,351,770 KRW, which provides some flexibility for reinvestment or shareholder returns. However, the negative operating cash flow of -331,254,180 KRW suggests that the company is not generating sufficient cash from its core operations to cover its expenses.

    The risk assessment for Protia Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and substantial cash reserves contribute to its strong liquidity position. There is no evidence of dilution potential in the basic shares outstanding, as the number of diluted shares is the same as the basic shares. The absence of dilution risk is a positive factor for shareholders.

    Recent events and filings do not show any significant changes or developments that would impact the company's financial position or strategic direction. The company's last actual EPS was 347.00 KRW, and the last actual revenue was 15,120,000,000 KRW, according to analyst estimates. These figures provide a baseline for assessing the company's performance against industry benchmarks and future expectations.

    Key takeaways
    • Protia Inc has a strong liquidity position with a high current ratio and substantial cash reserves.
    • The company's profitability metrics, such as ROE and ROA, are relatively low, indicating the need for operational improvements.
    • The company's revenue is concentrated in the healthcare services and equipment sector, with no disclosed geographic diversification.
    • Protia Inc has low liquidity and dilution risks, supported by its conservative capital structure and no immediate filing-based flags.
    • The company's free cash flow is positive, but its operating cash flow is negative, suggesting challenges in core operations.
    • "margin_outlook_rationale": "The company's operating margin is negative, indicating a need for cost management improvements to enhance profitability.",

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Net income surged 427.5% year-over-year to 4.47 billion KRW, demonstrating significant recent profitability improvement.

    Operating income expanded 801.6% year-over-year, indicating a substantial recovery in core operational efficiency and margins.

    Free cash flow turned strongly positive at 3.81 billion KRW, reversing previous negative trends and improving liquidity.

    Long-term debt remains minimal at 240.9 million KRW, providing a conservative balance sheet with low leverage risk.

    BEAR CASE · 3

    Return on equity of 0.4% is significantly below the 1.4% cohort median, showing poor capital efficiency.

    Cash conversion ratio of -3.48 ranks in the bottom quartile, highlighting weak ability to generate cash from operations.

    High credit risk flag suggests potential vulnerabilities in the company's financial stability or debt servicing capacity.

    In focus — financials by report

    Annual
    ANNUALFiled 2026-01-26
    FY 2026 · Full-year highlights

    Revenue KRW 15.12B, +43,8% YoY; Operating income +138,4% YoY.

    RevenueKRW 15.12B+43,8 % YoY
    Operating incomeKRW 3.58B+138,4 % YoY
    Net incomeKRW 4.47B+83,1 % YoY
    Free cash flowKRW 3.81B+123,7 % YoY
    EPS
    Operating cash flowKRW 3.00B+109,2 % YoY
    Financials
    Income statement
    RevenueKRW 15.12B
    Gross profitKRW 9.30B
    Operating incomeKRW 3.58B
    Net incomeKRW 4.47B
    Margins
    Gross margin61.5%
    Operating margin23.7%
    Net margin29.6%
    FCF margin25.2%
    Balance sheet
    Total assetsKRW 33.03B
    Total liabilitiesKRW 2.33B
    Total equityKRW 30.70B
    Cash & equivalentsKRW 2.96B
    Long-term debtKRW 240.9M
    Cash flow
    Operating cash flowKRW 3.00B
    CapEx-KRW 1.12B
    Free cash flowKRW 3.81B
    SBC
    P&L flow · revenue → net income
    Revenue KRW 2.17BOperating costs KRW 2.33BFinance KRW 2.3MNet income KRW 95.2M
    Highlights
    • Revenue KRW 15.12B, +43,8% YoY
    • Operating income +138,4% YoY
    • Net income +83,1% YoY
    • Free cash flow +123,7% YoY
    • Net margin 29.6%

    Valuation FY

    Market price
    $4 210,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $23.79B
    Net cash
    $920.3M
    Current ratio
    14.1
    Debt / equity
    0.0
    ROA
    0.4%
    ROE
    0.4%
    Cash conversion
    -348.0%
    CapEx / revenue
    -1.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-7,6 %Below median
    Net Margin4,4 %Above median
    ROE0,4 %Below median
    Capex / Rev-1,2 %Above P75
    D/E0,01Above P75
    Cash Conv-3,48Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Protia Inc Market data — financials · 2026-05-26
    • Protia Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Leadership

    • Guk Jin YimPresident, Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    303360.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-01-26 12:37 UTCEARNINGSAnnual results — FY 2026 Revenue KRW 15.12B · Net KRW 4.47B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage